Back to Search Start Over

Endoscopic full-thickness resection and its treatment alternatives in difficult-to-treat lesions of the lower gastrointestinal tract: a cost-effectiveness analysis

Authors :
Martin Faehndrich
Torsten Beyna
Alexander Meining
Robert Thimme
Horst Neuhaus
David Albers
Arthur Schmidt
Thomas Frieling
Michael Birk
Juliane Behn
Helmut Messmann
Andreas Probst
Armin Kuellmer
Karel Caca
Martin Goetz
Brigitte Schumacher
Source :
BMJ Open Gastroenterology, Vol 7, Iss 1 (2020), BMJ Open Gastroenterology
Publication Year :
2020
Publisher :
BMJ, 2020.

Abstract

ObjectiveEndoscopic full-thickness resection (EFTR) has shown efficacy and safety in the colorectum. The aim of this analysis was to investigate whether EFTR is cost-effective in comparison with surgical and endoscopic treatment alternatives.DesignReal data from the study cohort of the prospective, single-arm WALL RESECT study were used. A simulated comparison arm was created based on a survey that included suggested treatment alternatives to EFTR of the respective lesions. Treatment costs and reimbursement were calculated in euro according to the coding rules of 2017 and 2019 (EFTR). R0 resection rate was used as a measure of effectiveness. To assess cost-effectiveness, the average cost-effectiveness ratio (ACER) and the incremental cost-effectiveness ratio (ICER) were determined. Calculations were made both from the perspective of the care provider as well as of the payer.ResultsThe cost per case was €2852.20 for the EFTR group, €1712 for the standard endoscopic resection (SER) group, €8895 for the surgical resection group and €5828 for the pooled alternative treatment to EFTR. From the perspective of the care provider, the ACER (mean cost per R0 resection) was €3708.98 for EFTR, €3115.10 for SER, €8924.05 for surgical treatment and €7169.30 for all pooled and weighted alternatives to EFTR. The ICER (additional cost per R0 resection compared with EFTR) was €5196.47 for SER, €26 533.13 for surgical resection and €67 768.62 for the pooled rate of alternatives. Results from the perspective of the payer were similar.ConclusionEFTR is cost-effective in comparison with surgical and endoscopic treatment alternatives in the colorectum.

Details

ISSN :
20544774
Volume :
7
Database :
OpenAIRE
Journal :
BMJ Open Gastroenterology
Accession number :
edsair.doi.dedup.....557925dee3112c7fe1b25670d4aa1def
Full Text :
https://doi.org/10.1136/bmjgast-2020-000449